About Quality by Design
Quality by Design is a company based in London (United Kingdom) founded in 2014 was acquired by RTI Surgical in October 2024. Quality by Design operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others.
- Headquarter London, United Kingdom
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Collagen Solutions Limited
- Date of Incorporation 15 Mar, 2013
- Jurisdiction LONDON, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Gov.uk
& 6 more
-
Employee Count
Not available
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Quality by Design
Unlock access to complete
Funding Insights of Quality by Design
Investors in Quality by Design
Quality by Design has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Gov.uk, Calculus Capital and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
UK venture capital investments are managed by Calculus Capital.
|
Locked | Locked | Locked | |
|
Private equity investment firm
|
Locked | Locked | Locked | |
|
Consumer advocacy, advice, transport, and taxation services are provided.
|
Locked | Locked | Locked |
Investor details for Quality by Design
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Quality by Design
Investment portfolio details for Quality by Design
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Quality by Design
Detailed financials for Quality by Design
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Quality By Design Comparisons
Peer comparison for Quality by Design
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Quality by Design
Quality by Design operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Korro Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
RNA-editing technologies are provided for precision medicine applications.
|
|
| Locked | Locked | Locked |
Dental implants and regenerative dentistry products are developed.
|
Detailed competitors of Quality by Design
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Quality By Design
Complete news archive for Quality by Design
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Quality by Design
Quality by Design was founded in 2014.
Quality by Design is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Jamal Rushdy is the current CEO of Quality by Design.
Quality by Design was founded in 2014 in London, United Kingdom, as a developer and manufacturer of biomaterials. Medical grade collagen components are produced using a proprietary platform. These components are applied in regenerative medicine, medical devices, and in vitro diagnostic products. Operations focus on the biomaterials sector, with emphasis on collagen-based solutions for healthcare applications.
Quality by Design's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Quality by Design has 7 investors. Key investors include Gov.uk, Calculus Capital, European Union, Scotland Government, and Seneca EIS Portfolio Fund.